Women's Health Innovation Summit 2023

Women's Health Innovation Summit, USA

Accelerating innovation, investment, research and partnerships, to improve the access and quality of healthcare for women worldwide.

Register your Interest
WestIn Copley Place, Boston, MA
14-15 September, 2023

The Innovation Showcase is a unique opportunity for emerging companies with a disruptive technology, product, or service to present in front of the industry’s most influential partners, investors, and decision makers.

WHY ATTEND?

Over the past five years, WHIS has become the #1 annual eventvthat connects the industry-leading stakeholders in women’s health.vWe unitevpharmaceutical companies, investors, medical devicesvcompanies, biotechs, startups, femtech, payers, researchers,HCPs, consultants, and beyond, looking to drive innovation atvthe convergence of healthcare and technology. As the industry collectively continues to work towards improving health outcomes for women, we’re expanding our focus to include more government representatives, policy makers and NPOS as we steer the conversation towards advocacy, access, and action in line with industry needs. With more opportunities than ever before, we’re delighted to welcome you.

Be part of moving the needle. View the 2022 agenda here for more information.

You’re propelling the industry. We’re providing the platform.

2023 SERIES ADVISORY BOARD

Author:

Alice Zheng

Principal
RH Capital

Alice Zheng

Principal
RH Capital

Author:

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Author:

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Author:

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences

Author:

Valerie Palmieri

Executive Chairwoman
Aspira Women's Health

Valerie Palmieri

Executive Chairwoman
Aspira Women's Health

Author:

Sandy Milligan

MD, JD, Head of R&D
Organon

Sandy Milligan

MD, JD, Head of R&D
Organon

Author:

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Author:

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Author:

Raymon uit de Bulten

Director Start-Up Venturing Leader
Philips

Raymon uit de Bulten

Director Start-Up Venturing Leader
Philips

Author:

Rachel Braun Scherl

Co-Founder & Managing Partner
SPARK Solutions for Growth

Rachel Braun Scherl

Co-Founder & Managing Partner
SPARK Solutions for Growth

Author:

Bethany Corbin

Senior Counsel
Legally Femtech

Bethany Corbin

Senior Counsel
Legally Femtech

2023 Innovation Showcase

The Innovation Showcase is a unique opportunity for emerging companies with a disruptive technology, product, or service to present in front of the industry’s most influential partners, investors, and decision makers.

Split across two days and focused on early-stage funding and later-stage funding, 24 start-up finalists, hand-picked by our Selection Committee, will spotlight their innovation, highlight their achievements, and gain industry exposure.

This year, we’re introducing prize bundles for the two winners, as well as an intimate drinks reception for all applicants who attend the summit.

APPLY HERE

Applications close July 7

PLEASE NOTE: IF YOU ARE A SUCCESSFUL FINALIST, A TICKET MUST BE PURCHASED TO ATTEND THE SUMMIT

Academic Poster Session: Verticals that Differently or Predominantly Affect Women

Apply to showcase your innovative research that focus on verticals that differently or predominantly affect women’s health. During this session, 5 academic posters will be displayed to our audience of potential partners, funders, and accelerators.

Submit your abstract for presentation.

2022 Testimonials & Success Stories

2023 Partners

Innovation Partner

Oncology Partner

Knowledge Partner

Platinum Partner

Gold Partner

Event Partners

Event & Media Partner

Media Partners

2022 Speakers

 

Kevin Ali

CEO
Organon

Kevin Ali

CEO
Organon

Kevin Ali

CEO
Organon
 

Carolee Lee

Founder & CEO
WHAM (Women's Health Access Matters)

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives.

Carolee Lee

Founder & CEO
WHAM (Women's Health Access Matters)

Carolee Lee

Founder & CEO
WHAM (Women's Health Access Matters)

Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

 

Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

 

Janine Clayton

Associate Director of Research for Women's Health
NIH

Janine Clayton

Associate Director of Research for Women's Health
NIH

Janine Clayton

Associate Director of Research for Women's Health
NIH
 

Alice Zheng, MD, MBA, MPH

Principal
RH Capital

Alice Zheng, MD, MBA, MPH

Principal
RH Capital

Alice Zheng, MD, MBA, MPH

Principal
RH Capital
 

Allison Watkins-Conti

Founder/CEO
Watkins-Conti

Allison Watkins-Conti

Founder/CEO
Watkins-Conti

Allison Watkins-Conti

Founder/CEO
Watkins-Conti
 

Chris Pagano

Director
Venture Labs Matter

Chris Pagano

Director
Venture Labs Matter

Chris Pagano

Director
Venture Labs Matter
 

Will Porteous

Chief Growth Officer
Maven Clinic

Will Porteous

Chief Growth Officer
Maven Clinic

Will Porteous

Chief Growth Officer
Maven Clinic
 

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences
 

Dora Hughes

Chief Medical Officer
The CMS Innovation Center at the Centers for Medicare & Medicaid Services

Dora Hughes

Chief Medical Officer
The CMS Innovation Center at the Centers for Medicare & Medicaid Services

Dora Hughes

Chief Medical Officer
The CMS Innovation Center at the Centers for Medicare & Medicaid Services
 

Tami L Wahl

Government Affairs, Public Policy
Modern Advocates

Tami L Wahl

Government Affairs, Public Policy
Modern Advocates

Tami L Wahl

Government Affairs, Public Policy
Modern Advocates
 

Jessica Federer

Managing Partner
Supernode Ventures

Jessica Federer

Managing Partner
Supernode Ventures

Jessica Federer

Managing Partner
Supernode Ventures
 

Gail Maderis

CEO & President
Antiva Biosciences

Gail Maderis

CEO & President
Antiva Biosciences

Gail Maderis

CEO & President
Antiva Biosciences
 

Sandy Milligan, MD, JD

Head of Research & Development
Organon

Sandy Milligan, MD, JD

Head of Research & Development
Organon

Sandy Milligan, MD, JD

Head of Research & Development
Organon
 

Sheena Gill

CEO
Cognitive Care

Sheena Gill

CEO
Cognitive Care

Sheena Gill

CEO
Cognitive Care
 

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

 

Laura Veroneau

Managing Partner
Optum Ventures

Laura Veroneau

Managing Partner
Optum Ventures

Laura Veroneau

Managing Partner
Optum Ventures
 

Rachel Robinson

Chief Operation Officer
MassMedic

Rachel Robinson

Chief Operation Officer
MassMedic

Rachel Robinson

Chief Operation Officer
MassMedic
 

Nadine Vogel

CEO
Springboard Enterprises

Nadine Vogel

CEO
Springboard Enterprises

Nadine Vogel

CEO
Springboard Enterprises
 

Stasia Obremskey

Managing Director
RH Capital

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar.

Stasia Obremskey

Managing Director
RH Capital

Stasia Obremskey

Managing Director
RH Capital

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar. She has lived for over 8 years in Bangkok, Thailand and Hong Kong, China. She began her consulting career as a management consultant with Bain & Company. Previously, she worked in investment banking for Morgan Stanley & Co. She holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.

 

Katie Schubert

Society of Women's Health Research

Katie Schubert

Society of Women's Health Research

Katie Schubert

Society of Women's Health Research
 

Diana Contreras

Chief Healthcare Officer
Planned Parenthood

Diana Contreras

Chief Healthcare Officer
Planned Parenthood

Diana Contreras

Chief Healthcare Officer
Planned Parenthood
 

Golnoush Golshirazi

CEO & Co-Founder
ScreenMe

Golnoush Golshirazi

CEO & Co-Founder
ScreenMe

Golnoush Golshirazi

CEO & Co-Founder
ScreenMe
 

Libby Greer,

Partner
Forbes Tate Partners

Libby Greer,

Partner
Forbes Tate Partners

Libby Greer,

Partner
Forbes Tate Partners
 

Shakun Sethi

CEO & Founder
Ticklelife

Shakun Sethi

CEO & Founder
Ticklelife

Shakun Sethi

CEO & Founder
Ticklelife
 

Chris Pagan

Director
Venture Labs Matter

Chris Pagan

Director
Venture Labs Matter

Chris Pagan

Director
Venture Labs Matter
 

Tania Small

Global Medical Affairs, Therapeutic Area Head and Chair of Diversity, Equity, and Inclusion R&D Council
GSK

Tania Small, MD is Global Medical Affairs Therapeutic Area Head of Oncology at GSK and Chair of the diversity, equity, and inclusion R&D Council. She has built and leads an organization of approximately 500 professionals focused on patient-driven science, breaking down the barriers to access and driving impactful and innovative solutions to improve the outcome of individuals with cancers. Dr. Small was trained in Hematology/Oncology and bone marrow transplant at Columbia University, New York Presbyterian where she also completed a genetic research fellowship.

Tania Small

Global Medical Affairs, Therapeutic Area Head and Chair of Diversity, Equity, and Inclusion R&D Council
GSK

Tania Small

Global Medical Affairs, Therapeutic Area Head and Chair of Diversity, Equity, and Inclusion R&D Council
GSK

Tania Small, MD is Global Medical Affairs Therapeutic Area Head of Oncology at GSK and Chair of the diversity, equity, and inclusion R&D Council. She has built and leads an organization of approximately 500 professionals focused on patient-driven science, breaking down the barriers to access and driving impactful and innovative solutions to improve the outcome of individuals with cancers. Dr. Small was trained in Hematology/Oncology and bone marrow transplant at Columbia University, New York Presbyterian where she also completed a genetic research fellowship. She subsequently continued her focused on both hematology and stem cell transplant.
She has done research in oncology, hematology, gene therapy and stem cell transplantation, and received grants from the U.S. National Institutes of Health (NIH) for her translational research in gene therapy and regenerative medicine.
In previous roles with Novartis Oncology and Ipsen, Dr. Small successfully led the launch programs of multiple oncology therapies while overseeing both clinical development programs as well as medical affairs programs.


She has also led many patient-centered and diversity initiatives in previous roles, working closely with the U.S. FDA, Congress and the American Society of Clinical Oncology (ASCO) to improve the diversity enrollment into oncology clinical trials and elderly programs.
She is passionate about creating a world class oncology program that will successfully deliver the transformational medicines needed to revolutionize the experience and outcomes of patients.

 

Anna Daily

Founder
Namida Lab

Anna Daily

Founder
Namida Lab

Anna Daily

Founder
Namida Lab
 

Oriana Papin-Zoghbi

CEO & Co-Founder
AOA Dx

Oriana Papin-Zoghbi

CEO & Co-Founder
AOA Dx

Oriana Papin-Zoghbi

CEO & Co-Founder
AOA Dx
 

Brian Wilson

New Business Development Partner, Pharma and Medical Businesses
Celanese

Brian Wilson

New Business Development Partner, Pharma and Medical Businesses
Celanese

Brian Wilson

New Business Development Partner, Pharma and Medical Businesses
Celanese
 

Gurjeet Singh

CEO
Oma Fertility

Gurjeet Singh

CEO
Oma Fertility

Gurjeet Singh

CEO
Oma Fertility
 

Kathryn Capanna

Assistant Director of CDHR and Strategic Programs
FDA

Kathryn Capanna

Assistant Director of CDHR and Strategic Programs
FDA

Kathryn Capanna

Assistant Director of CDHR and Strategic Programs
FDA
 

Audrey Sheppard

President
Audrey Sheppard Women's Health Consulting

Audrey Sheppard

President
Audrey Sheppard Women's Health Consulting

Audrey Sheppard

President
Audrey Sheppard Women's Health Consulting
 

Suzanne Steinbaum

CEO & Founder
Heart-tech Health

Suzanne Steinbaum

CEO & Founder
Heart-tech Health

Suzanne Steinbaum

CEO & Founder
Heart-tech Health
 

Michael Annichine

CEO
Magee-Womens Research Institution

Michael Annichine

CEO
Magee-Womens Research Institution

Michael Annichine

CEO
Magee-Womens Research Institution
 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
The National Institute of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
The National Institute of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
The National Institute of Health (NIH)
 

Ru-fong Cheng

MD, FACOG, Director, Women’s Health Innovations
Bill & Melinda Gates Foundation

Ru-fong Cheng

MD, FACOG, Director, Women’s Health Innovations
Bill & Melinda Gates Foundation

Ru-fong Cheng

MD, FACOG, Director, Women’s Health Innovations
Bill & Melinda Gates Foundation
 

Candace Tingen

Program Officer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Candace Tingen

Program Officer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Candace Tingen

Program Officer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Register your interest for 2023

We are busy planning our 2023 Summit. To see a flavour of what's to come, fill in your details in the form and view our 2022 programme. You will be the first to hear when our 2023 agenda is released!

View the 2022 agenda

REGISTRATION - PRE-LAUNCH TICKETS

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Ticket price will increase in

Friday, September 30, 2022 to Friday, September 15, 2023
NPO/Charity/Government/Clinician Rate
$599
21 tickets remaining at this rate
Saturday, April 1, 2023 to Friday, May 19, 2023
Emerging/Start-ups
$899
Super Super Early Bird
Start-Up/Emerging Organisations
FemTech
MenoTech
Accelerators
Friday, February 3, 2023 to Friday, May 19, 2023
Industry
$1,799
Super Super Early Bird
Pharmaceutical Companies
Consumer Goods
Medical Device
Biotechnology
Payors/Insurance
Employers
Friday, February 3, 2023 to Friday, May 19, 2023
Service Providers
$2,499
Super Super Early Bird
Consultancies
Financial Advisors
Lawyers
CROs
Laboratories
Preparing registration...

Venue Description

Venue

The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, MA, 02116

Step into a AAA Four-Diamond hotel in downtown Boston's celebrated Back Bay area - a short stroll from fine dining destinations and upscale clothing stores in the popular Copley Place shopping mall. The Westin Copley Place, Boston welcomes guests with modern hotel accommodations and signature touches.

Boston Symphony Hall, Fenway Park and other downtown attractions are within easy reach of our hotel. In the evening, retreat to beautifully appointed hotel rooms and suites featuring stylish decor, the plush Westin Heavenly® Bed and spacious bathrooms.

Book your room! 

Our preferential room rate will be available shortly. 

 

 

Interested in sponsoring?

Please email [email protected] for all sponsorship and exhibition enquiries.

AUDIENCE BREAKDOWN

Big Pharma and Medical Device

At the forefront of women’s health innovation, Big Pharma and Medical Device companies play an important role at the Women’s Health Innovation Summit.

Startups

At the centre of our summit, we are committed to bringing together emerging
companies in women’s health, at all stages of growth and development who are
looking for partnership opportunities and are at the forefront of shaping the future of women’s health in this ever-changing landscape.

Investors

We look to bring together leading women’s health investors, alongside those
with an interest or focus on specific areas within women’s health. Investors
range from seed, to angel, venture capital firms, private equity, funds, and
advisors.

Servicing

Industry support and service providers include advocacy groups, researchers, knowledge leaders and accelerators such as consultants, lawyers, CROs, non-profits and regulatory experts.

Employers

This year, we’re looking expand the scope of stakeholders and hear more from employers, who play an important role in the women’s care across the world.

Payers/Insurers

Payers and insurance companies provide an important bridge between stakeholders within the women’s health industry, and we are delighted to have more joining us at this years’ summit.

FMCGs

Fast moving consumer goods companies play an important role in the women’s health landscape and include companies such as J&J, P&G.

Partner With Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected]

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Healthy Aging Summit

Women's Health Innovation Summit, Europe

Reproductive Health Innovation Summit